Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
Exhibit 99.1
POMDOCTOR LIMITED Expands Platform Integration
With Online Medical Insurance Coverage Across Major Chinese Cities
GUANGZHOU, China, February 4, 2026 /PRNewswire/
- POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (NASDAQ: POM), a leading online medical services platform for
chronic diseases in China, today announced a strategic initiative to deepen the integration of its platform with China’s national
and local coordinated medical insurance systems across major cities nationwide. This initiative is expected to significantly expand the
Company’s market reach and enhance its service offerings, delivering greater convenience and richer functionality for partner internet
hospitals, pharmacies, and patients.
Since 2018, China has actively promoted internet-based
medical services through a series of policy guidelines, industry standards, and administrative measures, including provisions enabling
online medical insurance reimbursement. In response, provincial and municipal implementation plans have been rolled out steadily, particularly
in core economic regions such as Guangdong Province and city clusters within the Greater Bay Area. These regional policies support the
development of the “internet + healthcare” ecosystem by establishing standards for internet hospitals, facilitating outpatient
care for chronic diseases, and enabling medical insurance payments for eligible online medical services.
This policy trajectory represents a pivotal pathway
for the digital transformation of China’s healthcare system, reshaping traditional models of medical service delivery. Leveraging
this favorable macro environment, Pomdoctor has been proactively expanding its platform services in key cities by integrating with local
online medical insurance payment systems. For example, in Guangzhou—where online insurance payment infrastructure is relatively
mature—the Company has successfully supported medical insurance settlements for chronic and special disease outpatients for more
than two years. This experience provides a strong operational benchmark for Pomdoctor’s planned expansion into other Greater Bay
Area cities, including Foshan (planned for the first quarter of 2026), Zhuhai, Shenzhen, Dongguan, and Huizhou.
In parallel, the Company is prioritizing expansion
in municipalities such as Beijing, Shanghai, and Tianjin, as well as major regional centers including Chengdu, Xi’an, Nanjing, Hangzhou,
and Fuzhou. These cities generally feature progressive medical insurance policies, fewer household registration restrictions, more efficient
cross-provincial settlement mechanisms, and enhanced payment facilitation, offering significant opportunities for scalable growth.
Integration with medical insurance systems substantially
strengthens the value proposition of Pomdoctor’s platform, which combines online physician consultations with home-delivered medications.
Compared with the often time-consuming process of visiting physical hospitals, patients can now, through the Company’s mobile app
or WeChat mini-program, complete online consultations, receive digital prescriptions, submit documentation for near-real-time insurance
reimbursement, and have prescribed medications delivered directly to their homes.
Mr. Zhenyang Shi, Chairman and Chief Executive
Officer of Pomdoctor, commented, “The convergence of internet-based healthcare services and medical insurance payment systems represents
a defining trend in the evolution of China’s healthcare ecosystem. For patients, it translates into more accessible care with reduced
time and financial burdens; for physicians, it enables more efficient use of time and broader service reach; and for the healthcare system
as a whole, it improves resource allocation and helps address regional imbalances in medical resources.
“Moreover, China’s internet healthcare
industry has moved beyond its exploratory phase and entered a stage of in-depth development characterized by standardization, scale, and
ecosystem integration. It has become an indispensable component of the national healthcare system, with an increasing emphasis on quality,
compliance, and long-term sustainability. As an established platform operator, we believe our network, technical capabilities, and operational
experience will be further amplified through deeper integration with local medical insurance systems. Looking ahead, we remain committed
to creating sustainable value for our shareholders while contributing positively to the broader healthcare industry and society.”
About POMDOCTOR LIMITED
POMDOCTOR LIMITED is a leading online medical
services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market based on the number of contracted
doctors in 2022, according to Frost & Sullivan. Focusing on chronic disease management and pharmaceutical services, the Company offers
a one-stop platform for medical services, organically connecting patients with doctors and pharmaceutical products. The Company’s
operations primarily include Internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals,
and other healthcare participants. Through this model, POMDOCTOR aims to enhance the efficiency and transparency of the healthcare value
chain. The Company’s mission is to provide effective prevention and treatment solutions to alleviate patients’ sufferings
from illnesses. Its vision is to become the most trustworthy medical and healthcare services platform. For more information, please visit
the Company’s website: http://ir.7shiliu.com.
Forward-Looking Statements
Certain statements in this announcement are forward-looking
statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current
expectations and projections about future events that the Company believes may affect its financial condition, results of operations,
business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,”
“believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,”
“intends,” “plans,” “will,” “would,” “should,” “could,” “may”
or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect
subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes
that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn
out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages
investors to review other factors that may affect its future results in the Company’s filings with the SEC.
For more information, please contact:
POMDOCTOR LIMITED
Investor Relations Department
Email: ir@7lk.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
